Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.50 |
| ▸ | MEN1 | O00255 | 6/20 | 0.50 |
| ▸ | S100A4 | P26447 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | PIM1 | P11309 | 1/20 | 0.44 |
| ▸ | CDC25B | P30305 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | NPC1 | O15118 | 4/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | HBB | P68871 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29689764 | 1.00 | KMT2A (0.50) | KMT2AMEN1S100A4POLBMAPT | |
| SCHEMBL16168528 | 0.86 | MEN1 (0.43) | KMT2AMEN1S100A4POLBMAPT | |
| SCHEMBL11966872 | 0.81 | GSTP1 (0.38) | KMT2AMEN1S100A4POLBMAPT | |
| SCHEMBL14391531 | 0.75 | PTPRC (0.32) | KMT2AMEN1CDC25BPTPRC | |
| SCHEMBL8406222 | 0.75 | CA1 (0.41) | KMT2AMEN1POLBMAPTPIM1 | |
| SCHEMBL8406221 | 0.75 | ADORA2A (0.44) | KMT2AMEN1POLBMAPTLMNA | |
| SCHEMBL24123358 | 0.75 | GSTP1 (0.33) | KMT2AMEN1POLBTP53LMNA | |
| SCHEMBL10080214 | 0.75 | TSHR (0.41) | KMT2AMEN1S100A4POLBLMNA | |
| SCHEMBL12070597 | 0.74 | USP8 (0.41) | KMT2AMEN1S100A4POLBMAPT | |
| SCHEMBL19240498 | 0.74 | MEN1 (0.38) | KMT2AMEN1S100A4POLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0853618-B1 | SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL -AZAHETEROCYCLYLAMIDE COMPOUNDS | AVENTIS PHARMA INC (US) | 2011-08-17 | — | — | EP | claimed |
| WO-2024059825-A1 | SYSTEMS AND METHODS FOR QUANTIFYING USER OBSERVED VISUALIZATION OF FLUORESCENCE IMAGING AGENTS | STRYKER CORPORATION (US) | 2024-03-21 | — | — | WO | disclosed |
| US-20230265231-A1 | IMIDE-LINKED POLYMERIC PHOTOINITIATORS | ARKEMA FRANCE (FR) | 2023-08-24 | — | — | US | disclosed |
| US-20230265231-A1 | IMIDE-LINKED POLYMERIC PHOTOINITIATORS | ARKEMA FRANCE (FR) | 2023-08-24 | — | — | US | disclosed |
| US-20220073448-A1 | METHOD FOR SYNTHESIZING CARBOXY-CONTAINING ANTHRAQUINONE DERIVATIVE, CARBOXY-CONTAINING ANTHRAQUINONE DERIVATIVE PREPARED THEREBY, AND BATTERY SYSTEM COMPRISING SAME | CHINA SALT JINTAN CO., LTD. (CN) | 2022-03-10 | — | — | US | disclosed |
| US-10988810-B2 | Methods and materials for detection of mutations | PENTABASE APS (DK) | 2021-04-27 | — | — | US | disclosed |
| US-10910634-B2 | Electroactive ionic liquids and surface-modified substrates containing them | UNIVERSITÉ PARIS CITÉ (FR) | 2021-02-02 | — | — | US | disclosed |
| EP-3453038-B1 | ELECTROACTIVE IONIC LIQUIDS AND SURFACE-MODIFIED SUBSTRATES CONTAINING THEM | CENTRE NAT RECH SCIENT (FR) | 2020-12-16 | — | — | EP | disclosed |
| US-20200321533-A1 | COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE MATERIALS | THE SCRIPPS RESEARCH INSTITUTE | 2020-10-08 | — | — | US | disclosed |
| US-10649330-B2 | Resist composition, method of forming resist pattern, compound, and acid generator | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-05-12 | — | — | US | disclosed |
| EP-1701939-B1 | ANTHRAQUINONE COMPOUNDS AS ANTI CANCER COMPOUNDS | SOMANTA LTD (GB) | 2009-02-25 | — | — | EP | disclosed |
| US-20090044864-A1 | ORGANIC PHOTOSENSITIVE OPTOELECTRONIC DEVICES WITH TRIPLET HARVESTING | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-02-19 | — | — | US | disclosed |
| US-20090044864-A1 | ORGANIC PHOTOSENSITIVE OPTOELECTRONIC DEVICES WITH TRIPLET HARVESTING | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-02-19 | — | — | US | disclosed |
| US-20080176853-A1 | e.g. N-(2-chloro-6-methylphenyl)-3-ethoxyacrylamide; protein (tyrosine and serine/threonine) kinase inhibitor; variety of conditions and diseases; antiproliferative, anticarcinogenic, antiinflammatory, antiallergenic agent; autoimmune and neurodegenerative disorders | ABRAXIS BIOSCIENCE, INC. (US) | 2008-07-24 | — | — | US | disclosed |
| US-20080176853-A1 | e.g. N-(2-chloro-6-methylphenyl)-3-ethoxyacrylamide; protein (tyrosine and serine/threonine) kinase inhibitor; variety of conditions and diseases; antiproliferative, anticarcinogenic, antiinflammatory, antiallergenic agent; autoimmune and neurodegenerative disorders | ABRAXIS BIOSCIENCE, INC. (US) | 2008-07-24 | — | — | US | disclosed |
| WO-2007104318-A2 | OLIGONUCLEOTIDES COMPRISING SIGNALLING PAIRS AND HYDROPHOBIC NUCLEOTIDES, STEMLESS BEACONS, FOR DETECTION OF NUCLEIC ACIDS, METHYLATION STATUS AND MUTANTS OF NUCLEIC ACIDS | PENTABASE APS (DK) | 2007-09-20 | — | — | WO | disclosed |
| US-20070161730-A1 | Colored thermoplastic resin compositions for laser welding, anthraquinone colorants therefor and molded product therfrom | DUPONT POLYMERS, INC. | 2007-07-12 | — | — | US | disclosed |
| US-20070059556-A1 | Organic compound and organic light emitting device using the same | LG CHEM. LTD. (KR) | 2007-03-15 | — | — | US | disclosed |
| US-20070059556-A1 | Organic compound and organic light emitting device using the same | LG CHEM. LTD. (KR) | 2007-03-15 | — | — | US | disclosed |
| WO-2006116157-A9 | DIPEPTIDYL PEPTIDASE-IV INHIBITORS | ALANTOS PHARMACEUTICALS INC (US) | 2007-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220073448-A1 | METHOD FOR SYNTHESIZING CARBOXY-CONTAINING ANTHRAQUINONE DERIVATIVE, CARBOXY-CONTAINING ANTHRAQUINONE DERIVATIVE PREPARED THEREBY, AND BATTERY SYSTEM COMPRISING SAME | ACMSD, PROC, AAAS | KMT2A 1820/4885MEN1 3058/4885S100A4 241/4885 |
| US-20200321533-A1 | COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE MATERIALS | ALDH1A2, DDT, CLTB | KMT2A 2223/4885MEN1 2493/4885S100A4 1350/4885 |
| US-10649330-B2 | Resist composition, method of forming resist pattern, compound, and acid generator | MCM4, RFC4, ATP1A4 | KMT2A 2406/4885MEN1 143/4885S100A4 50/4885 |
| US-20070059556-A1 | Organic compound and organic light emitting device using the same | SLCO4C1, TRPA1, OR51E2 | KMT2A 3606/4885MEN1 2364/4885S100A4 3291/4885 |
| US-20080176853-A1 | e.g. N-(2-chloro-6-methylphenyl)-3-ethoxyacrylamide; protein (tyrosine and serine/threonine) kinase inhibitor; variety of conditions and diseases; antiproliferative, anticarcinogenic, antiinflammatory, antiallergenic agent; autoimmune and neurodegenerative disorders | MAP3K15, DSTYK, STK25 | KMT2A 790/4885MEN1 2868/4885S100A4 1594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.